Related Experiment Video
Updated: Jun 23, 2025
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
15.6K
Drug disposition in cholestasis: An important concern.
Tianze Shang1, Chengliang Zhang1, Dong Liu1
1Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pharmacology Research & Perspectives
|June 20, 2024
Summary
Cholestasis alters drug metabolism enzymes and transporters (DMETs), affecting how the body processes medications. Understanding these changes is crucial for safe and effective drug selection and dosing in patients with this liver condition.
Area of Science:
- Hepatology
- Pharmacology
- Biochemistry
Background:
- Cholestasis is a chronic liver disease impacting bile acid homeostasis.
- This condition significantly complicates drug disposition and patient treatment.
- Drug metabolism enzymes and transporters (DMETs) are critical for drug clearance.
Purpose of the Study:
- To review alterations in hepatic and extrahepatic DMETs during cholestasis.
- To focus on changes in cytochrome P450 (CYP450) and drug transporters.
- To discuss drugs that can restore DMET expression in cholestasis.
Main Methods:
- Literature review synthesizing existing research on DMETs in cholestasis.
- Analysis of studies documenting changes in DMET expression and function in rodents and humans.
- Examination of drug substrates affected by cholestasis-induced DMET modifications.
Main Results:
- Cholestasis induces significant modifications in the expression and function of key DMETs.
- Both cytochrome P450 enzymes and drug transporters are affected, altering drug metabolism.
- Changes in DMETs impact the disposition of various drug substrates.
Conclusions:
- Cholestasis profoundly affects drug disposition by altering DMETs.
- These alterations necessitate a reevaluation of drug selection and dosing strategies for cholestatic patients.
- Further research into therapeutic agents that restore DMET function is warranted.
Related Concept Videos
01:14Hepatic Drug Clearance: Role of Transporters
54
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
54
01:16Hepatic Drug Excretion: Influencing Factors
123
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
123
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
196
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
196
01:23Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K